Physician profile
Juan Sanchez
NPI 1952954539
$1,080.99
in general payments reported to CMS, 2019-2025
17 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $160 · 2024: $211 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Education: $24.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.17 |
| Education | $24.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.42 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $104.85 | 2024-2025 | Farxiga |
| Aurinia Pharma U.S., INC. | $98.40 | 2023-2024 | Lupkynis |
| Travere Therapeutics, INC. | $88.18 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $86.57 | 2024-2025 | Jynarque |
| Calliditas Therapeutics US INC. | $83.88 | 2024-2025 | Tarpeyo |
| Ani Pharmaceuticals, INC. | $78.39 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $76.60 | 2025 | Acthar |
| Scpharmaceuticals INC. | $64.75 | 2025 | |
| Lilly USA, LLC | $62.82 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $51.18 | 2025 | |
| Amgen INC. | $28.30 | 2025 | Krystexxa |
| Opko Pharmaceuticals, LLC | $24.82 | 2025 | Rayaldee |
| Glaxosmithkline, LLC. | $22.86 | 2025 | Benlysta |
| Ardelyx, INC. | $21.40 | 2025 | Ibsrela |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $16.45 | 2025 | |
| Shield Therapeutics INC | $13.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.